生存率-话题@MedSci

#生存率#

482篇内容 | 2842人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256465, encodeId=de1e1256465a6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DiabetesRes Clin Pr：糖尿病或不影响我国腹透患者生存率, objectType=article, longId=19816, objectId=a07e19816f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a07e19816f5, replyNumber=0, likeNumber=72, createdTime=2013-06-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a07e19816f5, moduleTitle=DiabetesRes Clin Pr：糖尿病或不影响我国腹透患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a07e19816f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256464, encodeId=aa8312564644d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO2013：Ⅰ期精原细胞瘤生存率高, objectType=article, longId=18985, objectId=596e1898560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=596e1898560, replyNumber=0, likeNumber=67, createdTime=2013-05-22, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=596e1898560, moduleTitle=ASCO2013：Ⅰ期精原细胞瘤生存率高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=596e1898560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256463, encodeId=e585125646335, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：肿瘤生长时间可作为结直肠癌患者总生存率预测较佳指标, objectType=article, longId=18709, objectId=1e5518e09ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e5518e09ab, replyNumber=0, likeNumber=54, createdTime=2013-05-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e5518e09ab, moduleTitle=JCO：肿瘤生长时间可作为结直肠癌患者总生存率预测较佳指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e5518e09ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256462, encodeId=7fd11256462f0, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：结直肠癌患者生存率预测新指标, objectType=article, longId=18665, objectId=f4611866536, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4611866536, replyNumber=0, likeNumber=60, createdTime=2013-05-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4611866536, moduleTitle=JCO：结直肠癌患者生存率预测新指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4611866536)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256461, encodeId=c5781256461b5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率, objectType=article, longId=17777, objectId=ebd21e777db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebd21e777db, replyNumber=0, likeNumber=80, createdTime=2013-04-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebd21e777db, moduleTitle=JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebd21e777db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256460, encodeId=928e1256460ee, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Oncol：中山大学谢芳云发现鼻咽癌行新辅助化疗在生存率方面优于辅助化疗, objectType=article, longId=17774, objectId=3b001e77444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b001e77444, replyNumber=0, likeNumber=64, createdTime=2013-04-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b001e77444, moduleTitle=Ann Oncol：中山大学谢芳云发现鼻咽癌行新辅助化疗在生存率方面优于辅助化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b001e77444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256459, encodeId=4b46125645973, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Clin Oncol：多摄入豆制品可提高肺癌生存率, objectType=article, longId=17408, objectId=da1b1e40872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da1b1e40872, replyNumber=0, likeNumber=65, createdTime=2013-04-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da1b1e40872, moduleTitle=J Clin Oncol：多摄入豆制品可提高肺癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da1b1e40872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256457, encodeId=f11b125645e31, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=SGO：腹膜内灌注化疗可提高卵巢癌患者生存率, objectType=article, longId=16838, objectId=74e316838d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74e316838d2, replyNumber=0, likeNumber=67, createdTime=2013-04-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74e316838d2, moduleTitle=SGO：腹膜内灌注化疗可提高卵巢癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74e316838d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256458, encodeId=148e1256458e6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=SGO:无铂化疗不能提高宫颈癌患者生存率, objectType=article, longId=16842, objectId=8e4616842bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e4616842bd, replyNumber=0, likeNumber=71, createdTime=2013-04-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e4616842bd, moduleTitle=SGO:无铂化疗不能提高宫颈癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e4616842bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256456, encodeId=0df6125645619, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2013AHA 美国提高院内心脏骤停生存率策略的共识建议, objectType=article, longId=16830, objectId=f67e1683074, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f67e1683074, replyNumber=0, likeNumber=58, createdTime=2013-04-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f67e1683074, moduleTitle=2013AHA 美国提高院内心脏骤停生存率策略的共识建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f67e1683074)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256455, encodeId=0283125645522, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Surg：直肠癌根治性切除术前输血不影响患者生存率, objectType=article, longId=16345, objectId=62191634516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62191634516, replyNumber=0, likeNumber=0, createdTime=2013-03-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62191634516, moduleTitle=Ann Surg：直肠癌根治性切除术前输血不影响患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62191634516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256454, encodeId=7a891256454b1, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：ICD一级预防患者生存率在临床试验和临床实践中相似, objectType=article, longId=14133, objectId=312314133d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=312314133d7, replyNumber=0, likeNumber=70, createdTime=2013-01-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=312314133d7, moduleTitle=JAMA：ICD一级预防患者生存率在临床试验和临床实践中相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=312314133d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256453, encodeId=c74512564531f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AHA2012年会：TAVI同行起搏器置入不改善生存率, objectType=article, longId=10937, objectId=79151093e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79151093e08, replyNumber=0, likeNumber=79, createdTime=2012-11-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79151093e08, moduleTitle=AHA2012年会：TAVI同行起搏器置入不改善生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79151093e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256452, encodeId=d1201256452ba, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, objectType=article, longId=10379, objectId=3aef103e954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aef103e954, replyNumber=0, likeNumber=63, createdTime=2012-10-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aef103e954, moduleTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aef103e954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256451, encodeId=6032125645150, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=预防性脑照射不能改善NSCLC患者生存率, objectType=article, longId=9735, objectId=f5449e3576, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5449e3576, replyNumber=0, likeNumber=0, createdTime=2012-09-14, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5449e3576, moduleTitle=预防性脑照射不能改善NSCLC患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5449e3576)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256450, encodeId=2a6f1256450fe, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：R-FC方案未改善老年MCL患者生存率, objectType=article, longId=9320, objectId=6afb9320b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6afb9320b0, replyNumber=0, likeNumber=61, createdTime=2012-08-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6afb9320b0, moduleTitle=NEJM：R-FC方案未改善老年MCL患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6afb9320b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256449, encodeId=3b7b1256449d2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=淋巴结阳性胃癌患者生存率与放疗有关, objectType=article, longId=6597, objectId=ea3e659e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea3e659e42, replyNumber=0, likeNumber=69, createdTime=2012-05-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea3e659e42, moduleTitle=淋巴结阳性胃癌患者生存率与放疗有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea3e659e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256447, encodeId=340e125644eaa, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：研究证实CABG较之PCI更有生存率优势, objectType=article, longId=4888, objectId=1b6b4888f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b6b4888f1, replyNumber=0, likeNumber=55, createdTime=2012-04-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b6b4888f1, moduleTitle=NEJM：研究证实CABG较之PCI更有生存率优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b6b4888f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256448, encodeId=d07e125644819, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：心脏起搏器可改善1型肌强直性营养不良患者生存率, objectType=article, longId=4904, objectId=e1e64904d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1e64904d6, replyNumber=0, likeNumber=55, createdTime=2012-04-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1e64904d6, moduleTitle=JAMA：心脏起搏器可改善1型肌强直性营养不良患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1e64904d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256446, encodeId=61e2125644683, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=[ACC2012]CABG较PCI有生存率优势, objectType=article, longId=4828, objectId=7342482806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7342482806, replyNumber=0, likeNumber=78, createdTime=2012-04-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7342482806, moduleTitle=[ACC2012]CABG较PCI有生存率优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7342482806)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DiabetesRes Clin Pr：糖尿病或不影响我国腹透患者生存率

2013-06-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO2013：Ⅰ期精原细胞瘤生存率高

2013-05-22

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：肿瘤生长时间可作为结直肠癌患者总生存率预测较佳指标

2013-05-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：结直肠癌患者生存率预测新指标

2013-05-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率

2013-04-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Oncol：中山大学谢芳云发现鼻咽癌行新辅助化疗在生存率方面优于辅助化疗

2013-04-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Clin Oncol：多摄入豆制品可提高肺癌生存率

2013-04-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

SGO：腹膜内灌注化疗可提高卵巢癌患者生存率

2013-04-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

SGO:无铂化疗不能提高宫颈癌患者生存率

2013-04-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2013AHA 美国提高院内心脏骤停生存率策略的共识建议

2013-04-07

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Surg：直肠癌根治性切除术前输血不影响患者生存率

2013-03-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：ICD一级预防患者生存率在临床试验和临床实践中相似

2013-01-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AHA2012年会：TAVI同行起搏器置入不改善生存率

2012-11-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ESMO年会：来那度胺治疗晚期前列腺癌生存率低

2012-10-14

医者仁心 (审核中...)

前往app查看评论内容

#生存率#

预防性脑照射不能改善NSCLC患者生存率

2012-09-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：R-FC方案未改善老年MCL患者生存率

2012-08-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

淋巴结阳性胃癌患者生存率与放疗有关

2012-05-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：研究证实CABG较之PCI更有生存率优势

2012-04-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：心脏起搏器可改善1型肌强直性营养不良患者生存率

2012-04-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

[ACC2012]CABG较PCI有生存率优势

2012-04-12

科室
- - 订阅+
  - 更多科室
工具
服务